Gallus is kind and patient
Semaglutide activates GLP-1 receptors to promote satiety and slower digestion, while tirzepatide targets both GLP-1 and GIP, which may lead to greater and sometimes faster weight loss
But animals themselves are not able to synthesize these pigments
Portion control becomes essential as appetite decreases on GLP-1 therapy
All volunteers had to abstain from other medications, supplementary vitamins, and alcohol intake for 2 weeks prior to enrollment and throughout the study
Results Characteristics of the study subjects The background characteristics of 40 subjects in this study were as follows: Male/female =27/13, abdominal or thoracic aortic aneurysm/aortic dissection/arteriosclerosis obliterans/other = 12/20/6/2, diabetic/non-diabetic = 13/26, age 68.0 13.4 years old, BMI 23.8 4.7 kg/m 2 , HbA1c 6.2 1.5%